RALLYBIO CORPORATION Earnings Per Share, Basic and Diluted
RALLYBIO CORPORATION (RLYB) reported Earnings Per Share, Basic and Diluted of -$0.48 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-10
- RALLYBIO CORPORATION earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.48.
- RALLYBIO CORPORATION earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.37.
- RALLYBIO CORPORATION earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$2.80.
- RALLYBIO CORPORATION earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.60.
- RALLYBIO CORPORATION earnings per share, basic and diluted for fiscal 2021 was -$1.84.
- RALLYBIO CORPORATION earnings per share, basic and diluted for fiscal 2020 was -$1.52.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.48 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | -$1.84 10-K · filed 2022-03-15 | |||
| 2021-09-30 | -$0.37 10-Q · filed 2021-11-10 | -$1.44 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | -$2.80 10-Q · filed 2021-09-09 | -$6.77 10-Q · filed 2021-09-09 | ||
| 2021-03-31 | -$0.60 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$1.52 10-K · filed 2022-03-15 | |||
| 2020-09-30 | -$0.32 10-Q · filed 2021-11-10 | -$1.01 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$1.85 10-Q · filed 2021-09-09 | -$3.81 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |